607 related articles for article (PubMed ID: 26926467)
1. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
Hang P; Guo J; Sun C; Du Z
Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
[TBL] [Abstract][Full Text] [Related]
2. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
3. Small Molecules with Big Impacts on Cardiovascular Diseases.
Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
[TBL] [Abstract][Full Text] [Related]
4. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Signature and Cardiovascular Dysfunction.
Arunachalam G; Upadhyay R; Ding H; Triggle CR
J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
[TBL] [Abstract][Full Text] [Related]
6. The role of miR-214 in cardiovascular diseases.
Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
Wang F; Chen C; Wang D
Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in cardiovascular disease: an introduction for clinicians.
Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA and Cardiovascular Diseases.
Çakmak HA; Demir M
Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.
Huang Y; Li J
J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNAs as biomarkers in cardiovascular diseases.
Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: role in cardiovascular biology and disease.
Zhang C
Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
[TBL] [Abstract][Full Text] [Related]
14. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
Yan B; Wang H; Tan Y; Fu W
Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
[TBL] [Abstract][Full Text] [Related]
15. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.
Wang J; Liew OW; Richards AM; Chen YT
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331
[TBL] [Abstract][Full Text] [Related]
16. HDL and microRNA therapeutics in cardiovascular disease.
Michell DL; Vickers KC
Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
[TBL] [Abstract][Full Text] [Related]
17. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
Wronska A
J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: roles in cardiovascular development and disease.
Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
[TBL] [Abstract][Full Text] [Related]
19. [MicroRNAs: what cardiologists should know about them?].
Mericskay M
Presse Med; 2015; 44(7-8):761-71. PubMed ID: 26163829
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
Pan ZW; Lu YJ; Yang BF
Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
